Neuroone Medical Technologies NMTC
NASDAQ NMTC
$1.66 -0.03 (-1.78%)
At close: Sep 9, 2026 · 4:00 PM EDT

Neuroone Medical Technologies (NMTC) Raw Materials (2023)

Neuroone Medical Technologies' (NMTC) quarterly Raw Materials came in at $1.0 million in Q4 2023, down 13.21% quarter-over-quarter from $1.2 million in Q3 2023.

Analysis

Neuroone Medical Technologies (NMTC) Raw Materials (2023) Analysis & Trends

Neuroone Medical Technologies (NMTC) has reported Raw Materials for 1 consecutive years, with $1.0 million the latest figure, recorded in Q4 2023.

  • For the quarter ending Q4 2023, Raw Materials changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2023 stood at $1.0 million (changed N/A YoY), and the FY2023 full-year result was $1.2 million, changed N/A from the prior year.
  • Raw Materials retreated to $1.0 million in Q4 2023 per NMTC's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $1.2 million in Q3 2023 and bottomed at $1.0 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Neuroone Medical Technologies 14.33 Mn 12.29 Mn 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.20 Mn